BridgeMD
New treatment option for Calculous Anuria
Official title Initial Drainage Method and Flexible Ureteroscopy Outcomes in Calculous Anuria
ClinicalTrials.gov ID: NCT07627880
What this study is testing
- What it's testing
- Calculous anuria caused by obstructing upper ureteral stones in a solitary functioning kidney is a urological emergency requiring urgent decompression. Both retrograde JJ ureteral stenting and percutaneous nephrostomy are commonly used emergency drainage methods.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older.
- Calculous anuria secondary to a single upper ureteral stone.
- Solitary functioning kidney, whether anatomical or functional.
- Single upper ureteral stone confirmed by non-contrast computed tomography.
- Stone size from 6 mm to 20 mm in maximum diameter.
You likely can't join if
- Multiple stones or bilateral stones not fitting the solitary-kidney study design.
- Renal pelvic, distal ureteral, or multiple ipsilateral stones.
- Stone burden greater than 20 mm.
- Septic shock, hemodynamic instability, or need for emergency dialysis at presentation.
- Pyonephrosis requiring a non-assigned by chance drainage decision.
- Anatomical abnormalities affecting endoscopic access, such as horseshoe kidney, pelvic kidney, ureterocele, or ureteral stricture.
See the full eligibility criteria
- Adults aged 18 years or older.
- Calculous anuria secondary to a single upper ureteral stone.
- Solitary functioning kidney, whether anatomical or functional.
- Single upper ureteral stone confirmed by non-contrast computed tomography.
- Stone size from 6 mm to 20 mm in maximum diameter.
- Patient considered suitable for either initial JJ ureteral stent drainage or percutaneous nephrostomy drainage.
- Candidate for definitive treatment by flexible ureteroscopy/retrograde intrarenal surgery.
- Documented renal functional improvement and clinical stabilization before definitive RIRS.
- Negative or appropriately treated urine culture before definitive RIRS.
- Ability and willingness to provide written informed consent.
- Multiple stones or bilateral stones not fitting the solitary-kidney study design.
- Renal pelvic, distal ureteral, or multiple ipsilateral stones.
- Stone burden greater than 20 mm.
- Septic shock, hemodynamic instability, or need for emergency dialysis at presentation.
- Pyonephrosis requiring a non-assigned by chance drainage decision.
- Anatomical abnormalities affecting endoscopic access, such as horseshoe kidney, pelvic kidney, ureterocele, or ureteral stricture.
- Previous ipsilateral ureteral reconstructive surgery.
- Uncorrected coagulopathy.
- Pregnancy.
- Genitourinary malignancy.
- Inability to complete follow-up.
The study team makes the final eligibility decision.
Where it's taking place
- Banī Suwayf, Beni Suweif Governorate, Egypt
- Minya, Minya Governorate, Egypt
- Tanta, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banī Suwayf, Beni Suweif Governorate, Egypt; Minya, Minya Governorate, Egypt; Tanta, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.